Simplex Trading’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $968K | Buy |
+55,934
| New | +$968K | ﹤0.01% | 418 |
|
|
2025
Q1 | – | Hold |
0
| – | – | – | 2367 |
|
|
2024
Q4 | – | Sell |
-73,982
| Closed | -$2.13M | – | 2414 |
|
|
2024
Q3 | $2.13M | Buy |
73,982
+3,910
| +6% | +$113K | ﹤0.01% | 257 |
|
|
2024
Q2 | $2.69M | Buy |
+70,072
| New | +$2.69M | ﹤0.01% | 219 |
|
|
2024
Q1 | – | Sell |
-44,954
| Closed | -$2.69M | – | 2338 |
|
|
2023
Q4 | $2.69M | Sell |
44,954
-31,911
| -42% | -$1.91M | ﹤0.01% | 236 |
|
|
2023
Q3 | $2.92M | Buy |
76,865
+854
| +1% | +$32.5K | ﹤0.01% | 158 |
|
|
2023
Q2 | $6.92M | Buy |
76,011
+72,588
| +2,121% | +$6.61M | 0.01% | 77 |
|
|
2023
Q1 | $225K | Buy |
+3,423
| New | +$225K | ﹤0.01% | 757 |
|
|
2022
Q4 | – | Sell |
-29,627
| Closed | -$2.02M | – | 2485 |
|
|
2022
Q3 | $2.02M | Buy |
29,627
+19,463
| +191% | +$1.33M | ﹤0.01% | 211 |
|
|
2022
Q2 | $459K | Buy |
10,164
+7,197
| +243% | +$325K | ﹤0.01% | 580 |
|
|
2022
Q1 | $150K | Buy |
+2,967
| New | +$150K | ﹤0.01% | 1233 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 2974 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 2789 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 2830 |
|
|
2021
Q1 | – | Sell |
-1,456
| Closed | – | – | 2504 |
|
|
2020
Q4 | $0 | Sell |
1,456
-2,808
| -66% | – | ﹤0.01% | 2307 |
|
|
2020
Q3 | $0 | Sell |
4,264
-261
| -6% | – | ﹤0.01% | 2108 |
|
|
2020
Q2 | $147K | Sell |
4,525
-1,429
| -24% | -$46.4K | ﹤0.01% | 865 |
|
|
2020
Q1 | $159K | Buy |
+5,954
| New | +$159K | ﹤0.01% | 801 |
|
|
2019
Q4 | – | Sell |
-2,489
| Closed | -$59K | – | 1921 |
|
|
2019
Q3 | $59K | Buy |
2,489
+2,414
| +3,219% | +$57.2K | ﹤0.01% | 1032 |
|
|
2019
Q2 | $1K | Buy |
+75
| New | +$1K | ﹤0.01% | 1669 |
|